In the media

Cardiovascular News

Long-term study indicates no calcification with CardioCel after eight years

22, August, 2016

Posted In: In the media

Long-term data from a Phase II extension study for the repair of congenital heart defects in paediatrics using CardioCel shows that all patients continue to progress well, with no sign of calcification or need for repeat procedures.

> Read more

mass device logo

Admedus shares rise on hospital infusion pump supply deal with Arcomed

25, May, 2016

Posted In: In the media, Featured

Admedus said today it won a supply contract with the new Royal Adelaide Hospital for the installation of the Arcomed chroma infusion pump systems. The supply tender includes ongoing technical and clinical support as well as consumable products for the systems over the next 5 years.

> Read more

Manufacturing-Award

Admedus Wins 2016 Australian Manufacturer of the Year Award

14, May, 2016

Posted In: In the media, Featured

After triumphing in the Most Innovative category, Admedus also took out the night’s biggest award ‘Manufacturer of the Year’. In August 2014 Admedus opened its state-of-the-art bio-manufacturing facility in Malaga, WA, and has experienced huge success in exporting its bio-scaffold regenerative medicine product, CardioCel, since then.

> Read more

Channel 7 News – A world first treatment for HPV

22, March, 2016

Posted In: Videos, In the media

> Watch the video

The Australian Logo

Admedus HSV-2 clinical results encouraging – Morgans

7, March, 2016

Posted In: In the media, Featured

Morgans healthcare analyst Scott Power talks to The Australian about Admedus’s HSV-2 Phase II clinical trial results.

> Read more

huffington post

Gardasil creator is testing a DNA vaccine to wipe out cancer-causing HPV virus

1, March, 2016

Posted In: In the media

Professor Ian Frazer (the creator of Gardasil) is working with healthcare company Admedus to create a DNA vaccine which could be injected in people who already have HPV to stop it progressing to cervical cancer. Admedus Chief Scientific Officer Dr David Rhodes said the technology developed by Admedus in conjunction with Frazer could potentially be applied to a […]

> Read more

Repair7

Performance and versatility of a new tissue engineered collagen scaffold in cardiovascular surgery

24, February, 2016

Posted In: In the media

Professor Leon Neethling was published in the February 2016 edition of Pädiatrische Kardiologie (German Pediatric Cardiology) journal where he discussed the performance and versatility of CardioCel in cardiovascular surgery. First publication: Lebendige Wissenschaft, Spitzenforschung Pädiatrische Kardiologie 2016; 96-466:46-47 Posted here with kind permission of Alpha Informationsgesellschaft mbH, Germany

> Read more

mass device logo

Admedus inks exclusive distro deal with Coroneo

27, January, 2016

Posted In: In the media

Admedus (ASX:AHZ) has inked an exclusive distribution agreement with Coroneo to sell its extra aortic annuloplasty ring and other heart valve surgery instruments in Germany and the U.K.

> Read more

Cardiovascular News

CardioCel bio-scaffold launched and sold in Malaysia

4, November, 2015

Posted In: In the media, Featured

CardioCel has now been launched in Malaysia and the Company has achieved its first sales in the country.

> Read more

biotuesday

Admedus HSV-2 vaccine set for key value inflection point

22, September, 2015

Posted In: In the media

In an interview with leading online biotech site, BioTuesdays, Chief Operating Officer Julian Chick discusses Admedus’ anticipated interim results from a Phase 2 trial of its therapeutic vaccine for the treatment of herpes simplex virus-2 (HSV-2).

> Read more

mass device logo

Down-under medtech firm Admedus looks to future in bio-scaffolds

11, September, 2015

Posted In: In the media

Admedus Chief Operating Officer Julian Chick spoke to MassDevice.com about the Company’s flagship product CardioCel, how it’s using bio-scaffolds to grow in the cardiac repair market and where it’s looking to take bio-scaffolds next.

> Read more

Ausbio

Biotech’s role in advanced manufacturing

5, September, 2015

Posted In: In the media, Featured

With an increase in Australian biotech companies moving their manufacturing off-shore, there has been a call for the Government to further support the sector through better R&D and tax incentives. Admedus Chief Operating Officer, Dr Julian Chick, discusses biotech’s role in advanced manufacturing in Australia and the work Admedus is doing at its state of the […]

> Read more